Androgen receptor alterations in prostatic carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (57)
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
1979 • 1,595 citations
Isolation of a human prostate carcinoma cell line (DU 145)
1978 • 1,176 citations
A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgens
1990 • 948 citations
The LNCaP cell line--a new model for studies on human prostatic carcinoma.
1980 • 531 citations
Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors.
1988 • 530 citations
Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization
1991 • 513 citations
The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element
1991 • 452 citations
Androgen receptor gene mutations in human prostate cancer.
1992 • 421 citations
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
1993 • 421 citations
Triplet repeat mutations in human disease
1992 • 417 citations
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
1993 • 417 citations
Androgen receptors in endocrine‐therapy‐resistant human prostate cancer
1991 • 390 citations
The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor
1992 • 381 citations
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
1994 • 364 citations
Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression
1991 • 303 citations
Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation
1992 • 284 citations
Autologous Down-Regulation of Androgen Receptor Messenger Ribonucleic Acid
1990 • 272 citations
Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.
1991 • 266 citations
Growth Regulation of Estrogen Receptor-Negative Breast Cancer Cells Transfected With Complementary DNAs for Estrogen Receptor
1992 • 263 citations
Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy
1991 • 242 citations
Androgen Receptor Assay with [3H]Methyltrienolone (R1881) in the Presence of Progesterone Receptors*
1979 • 223 citations
Androgen Resistance — The Clinical and Molecular Spectrum
1992 • 221 citations
Androgen receptor gene expression in human prostate carcinoma cell lines.
1990 • 220 citations
Aberrant response in vitro of hormone‐responsive prostate cancer cells to antiandrogens
1989 • 208 citations
Assay of androgen binding sites by exchange with methyltrienolone (R 1881)
1976 • 191 citations
Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP
1992 • 179 citations
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone
1993 • 178 citations
Antipeptide Antibodies to Two Distinct Regions of the Androgen Receptor Localize the Receptor Protein to the Nuclei of Target Cells in the Rat and Human Prostate*
1990 • 173 citations
Microsatellite Mutation (Cag24→18) in the Androgen Receptor Gene in Human Prostate Cancer
1994 • 166 citations
Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line.
1992 • 166 citations
Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: High affinity for progestagenic and estrogenic steroids
1990 • 165 citations
Correlation of Prostatic Nuclear Androgen Receptor Content with Duration of Response and Survival Following Hormonal Therapy in Advanced Prostatic Cancer
1982 • 160 citations
Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA.
1993 • 148 citations
Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids
1988 • 139 citations
Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP
1986 • 137 citations
Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptors
1992 • 136 citations
Chromosomal abnormalities and related events in prostate cancer
1992 • 120 citations
Image analysis of androgen receptor immunostaining in metastatic prostate cancer heterogeneity as a predictor of response to hormonal therapy
1993 • 117 citations
DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction
1993 • 117 citations
Androgen receptor heterogeneity in human prostatic carcinomas visualized by immunohistochemistry
1990 • 104 citations
Human prostate cancer model: Roles of growth factors and extracellular matrices
1992 • 95 citations
Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line
1992 • 87 citations
Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER.
1992 • 75 citations
The androgen receptor: Functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines
1990 • 70 citations
Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
1990 • 60 citations
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion
1990 • 59 citations
Steroid receptors in metastatic carcinoma of the human prostate
1979 • 57 citations
The use of radioactive 7α, 17α‐dimethyl‐19‐nortestosterone (mibolerone) in the assay of androgen receptors
1984 • 48 citations
Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line
1992 • 42 citations
Domain functions of the androgen receptor
1992 • 40 citations
Characterization of steroid receptors in human prostate using mibolerone
1986 • 33 citations
Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER
1992 • 32 citations
A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.
1987 • 30 citations
Relationship between androgen receptor binding activity in human prostate cancer and clinical response to endocrine therapy
1987 • 27 citations
Nuclear androgen receptor content in biopsy specimens from histologically normal, hyperplastic, and cancerous human prostatic tissue
1985 • 26 citations
Androgen receptors in biopsy specimens of prostate adenocarcinoma. Heterogeneity of distribution and relation to prognostic significance of receptor measurements for survival of advanced cancer patients
1987 • 25 citations
Prediction of time to progression after orchiectomy by the nuclear androgen receptor content from multiple biopsy specimens in patients with advanced prostate cancer
1988 • 19 citations